Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systematic Treatment Algorithms vs Treatment as Usual in Unipolar Depression
DRKS00000161Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amitriptyline, reboxetine, sertraline, venlafaxine, lithium and 2 more in major depressive disorder (MDD) and recurrent depressive disorder (RDD) (5 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Jul 2009; status: completed.
02
Drugs
amitriptylinereboxetinesertralinevenlafaxinelithium
03
Conditions
major depressive disorder (MDD)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on DRKS00000161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000161.